s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf ·...

9

Transcript of s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf ·...

Page 1: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 2: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 3: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 4: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 5: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 6: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 7: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 8: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250
Page 9: s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/1/Denardo.pdf · clinical applications, ... achieved in most cases (but not when using the ... (250

Behçet’s disease: A profile of mucocutaneous featuress3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · 12 Behçet’s disease: A profile of mucocutaneous features Clinical

Behçet’s disease: A profile of mucocutaneous featuress3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · 12 Behçet’s disease: A profile of mucocutaneous features Clinical

Cloud Object Storage | Store & Retrieve Data Anywhere ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · pigmented purpuras, its rare occurrence in children is surprising.

Cloud Object Storage | Store & Retrieve Data Anywhere ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · pigmented purpuras, its rare occurrence in children is surprising.

Lichen planus–like dermatosis with Blaschko line ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · Lichen planus–like dermatosis with Blaschko line distribution: a case

Lichen planus–like dermatosis with Blaschko line ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · Lichen planus–like dermatosis with Blaschko line distribution: a case

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1995/3/Bokal... · vaginosis. At least three of the following four criteria must be fulfilled to

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1995/3/Bokal... · vaginosis. At least three of the following four criteria must be fulfilled to

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/4/Blumenberg.pdf · Keratinocyte differentiation and activation Review paper KERATINOCYTE DIFFERENTIATION

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/.../10.15570/archive/1997/4/Blumenberg.pdf · Keratinocyte differentiation and activation Review paper KERATINOCYTE DIFFERENTIATION

Cloud Object Storage | Store & Retrieve Data Anywhere ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · Dermoabrasion - method of choice in treatment of morbus Darier Z.

Cloud Object Storage | Store & Retrieve Data Anywhere ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · Dermoabrasion - method of choice in treatment of morbus Darier Z.

A multicenter clinicomycological study evaluating the ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/acta-apa... · A multicenter clinicomycological study evaluating

A multicenter clinicomycological study evaluating the ...s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/acta-apa... · A multicenter clinicomycological study evaluating

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1997/2/Urbanowski.pdfvaginal and oral candidosis and other mycoses (6,7,8,9). MATERIALS AND METHODS

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1997/2/Urbanowski.pdfvaginal and oral candidosis and other mycoses (6,7,8,9). MATERIALS AND METHODS

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/...Acta Derm Venereol (Stockh) 1983; 63:9-13 5. Gebhardt M: Aeroallergens and atopic dermatitis. Contact

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/...Acta Derm Venereol (Stockh) 1983; 63:9-13 5. Gebhardt M: Aeroallergens and atopic dermatitis. Contact

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/...is a new drug of this class. Its activity against disseminated melanoma has been demonstrated in a large

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/...is a new drug of this class. Its activity against disseminated melanoma has been demonstrated in a large

Cervical cancer screening practices in central and eastern Europe …s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/acta-… · noticeable in Europe, where the cervical

Cervical cancer screening practices in central and eastern Europe …s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/acta-… · noticeable in Europe, where the cervical

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1999/3/... · Histopathology of psoriasis lesions may initially clinically simulate a variety of

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1999/3/... · Histopathology of psoriasis lesions may initially clinically simulate a variety of

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2002/2/... · glutination assay (MHA-TP) or T PHA (Treponema pallidum hemagglutination assay) ...

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2002/2/... · glutination assay (MHA-TP) or T PHA (Treponema pallidum hemagglutination assay) ...

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1994/1-2/...Lyme borreliosis. Alpe Adria. EPIDEMIOLOGY OF LYME BORRELIOSIS IN ALPE ADRIA AREA Simeoni,

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1994/1-2/...Lyme borreliosis. Alpe Adria. EPIDEMIOLOGY OF LYME BORRELIOSIS IN ALPE ADRIA AREA Simeoni,

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1992/2/Torok.pdfof aDegos papule a pronounced deposit ofimmune-complexes of mainly granular type

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1992/2/Torok.pdfof aDegos papule a pronounced deposit ofimmune-complexes of mainly granular type

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2001/4/... · Epidemiology of Lyme disease Table 1. Frequency of early manifestation of Lyme dis-

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2001/4/... · Epidemiology of Lyme disease Table 1. Frequency of early manifestation of Lyme dis-

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · 2014-07-20 · Resistance to chemotherapeutic agents can develop to particular drug or group of

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/... · 2014-07-20 · Resistance to chemotherapeutic agents can develop to particular drug or group of

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1998/3-… · The pharmacokinetic properties of cuwent systemic antifungal agents Formulation oral,

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/1998/3-… · The pharmacokinetic properties of cuwent systemic antifungal agents Formulation oral,

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2000/3/... · Mucosal involvement is common (mouth, nose or esophagus) so that erosions and ulcers

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2000/3/... · Mucosal involvement is common (mouth, nose or esophagus) so that erosions and ulcers

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2000/2/... · Hydrocortisone, predni- solone and alclometasone were among the first used for topical

s3-eu-west-1.amazonaws.coms3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/2000/2/... · Hydrocortisone, predni- solone and alclometasone were among the first used for topical